Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiro Saito

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Cancers|July 24, 2021
A Radiological Scoring System for Differentiation between Enchondroma and ChondrosarcomaShinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, et al.
International Journal of Clinical Oncology|June 24, 2018
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survivalKazuto Ito, Shiro Saito, Atsunori Yorozu, et al.
BMC Urology|September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional studyMikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
BJU International|December 2, 2008
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysisTakefumi Satoh, Hiromichi Ishiyama, Kazumasa Matsumoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 30, 2024
Japanese clinical practice guidelines for prostate cancer 2023Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, et al.
Journal of Radiation Research|October 24, 2015
Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapyHiromichi Ishiyama, Takefumi Satoh, Atsunori Yorozu, et al.
Cancer|June 24, 2020
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trialKazuto Ito, Mikio Kobayashi, Motokiyo Komiyama, et al.
Cancer Medicine|May 1, 2021
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trialAkira Yokomizo, Hirofumi Koga, Kazuto Ito, et al.
Journal of the National Cancer Institute|May 17, 2019
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer RadiotherapySarah L Kerns, Laura Fachal, Leila Dorling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate CancerManzur Farazi, Xin Yang, Carson J Gehl, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Cancers|July 24, 2021
A Radiological Scoring System for Differentiation between Enchondroma and ChondrosarcomaShinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, et al.
International Journal of Clinical Oncology|June 24, 2018
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survivalKazuto Ito, Shiro Saito, Atsunori Yorozu, et al.
BMC Urology|September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional studyMikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
BJU International|December 2, 2008
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysisTakefumi Satoh, Hiromichi Ishiyama, Kazumasa Matsumoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 30, 2024
Japanese clinical practice guidelines for prostate cancer 2023Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, et al.
Journal of Radiation Research|October 24, 2015
Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapyHiromichi Ishiyama, Takefumi Satoh, Atsunori Yorozu, et al.
Cancer|June 24, 2020
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trialKazuto Ito, Mikio Kobayashi, Motokiyo Komiyama, et al.
Cancer Medicine|May 1, 2021
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trialAkira Yokomizo, Hirofumi Koga, Kazuto Ito, et al.
Journal of the National Cancer Institute|May 17, 2019
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer RadiotherapySarah L Kerns, Laura Fachal, Leila Dorling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate CancerManzur Farazi, Xin Yang, Carson J Gehl, et al.
Pageof 12